Skip to main content

and
  1. No Access

    Article

    Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms

    Mrinal M. Patnaik, Amer M. Zeidan, Eric Padron, Uwe Platzbecker in Leukemia (2022)

  2. Article

    Open Access

    Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis

    Progressive bone marrow fibrosis (BMF) is a cardinal feature of many myeloproliferative neoplasms (MPNs) and there is a documented association between the severity of BMF and overall prognosis. We conducted an...

    Catriona Jamieson, Robert Hasserjian, Jason Gotlib in Journal of Translational Medicine (2015)